awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34050113-383FF44C-3871-4A7B-B781-CA8A227A35ED
Q34050113-383FF44C-3871-4A7B-B781-CA8A227A35ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34050113-383FF44C-3871-4A7B-B781-CA8A227A35ED
Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis
P2860
Q34050113-383FF44C-3871-4A7B-B781-CA8A227A35ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34050113-383FF44C-3871-4A7B-B781-CA8A227A35ED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cff55b9a0a0aa32e2b91341d2899e05442be077a
P2860
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.